Au­rinia share­hold­er calls for sale talks, nix­es sup­port for CEO and chair

A 4.2% share­hold­er of Au­rinia Phar­ma­ceu­ti­cals is call­ing on the drug­mak­er to find a buy­er and shake up its board to rid it of the CEO and chair.

MKT Cap­i­tal wrote to oth­er share­hold­ers Mon­day morn­ing that it wants a strate­gic re­view process to take place “im­me­di­ate­ly,” with the Cay­man Is­lands in­vest­ment firm think­ing a sale of the en­tire com­pa­ny could at­tract up to $28 per share from a bio­phar­ma or pri­vate eq­ui­ty ac­quir­er. The stock $AUPH was trad­ing at near­ly $11 on Mon­day morn­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER